Nuvation Bio Inc (NUVB)
2.57
-0.01
(-0.39%)
USD |
NYSE |
Apr 19, 16:00
2.57
0.00 (0.00%)
After-Hours: 20:00
Nuvation Bio Cash from Investing (TTM): 8.921M for Dec. 31, 2023
Cash from Investing (TTM) Chart
Historical Cash from Investing (TTM) Data
Date | Value |
---|---|
December 31, 2023 | 8.921M |
September 30, 2023 | -46.07M |
June 30, 2023 | 27.72M |
March 31, 2023 | 17.01M |
December 31, 2022 | 63.46M |
September 30, 2022 | -103.98M |
June 30, 2022 | -259.90M |
Date | Value |
---|---|
March 31, 2022 | -459.14M |
December 31, 2021 | -454.67M |
September 30, 2021 | -363.67M |
June 30, 2021 | -265.43M |
March 31, 2021 | -82.01M |
December 31, 2020 | -70.32M |
Cash From Investing Definition
Cash from Investing is a major line item of the statement of cash flows. This metric tracks the movement of cash flows for the overall investing activities of the company. A few examples of investing activities include net change in PP&E, and net divestitures.
Cash from Investing (TTM) Range, Past 5 Years
-459.14M
Minimum
Mar 2022
63.46M
Maximum
Dec 2022
-152.93M
Average
-82.01M
Median
Mar 2021
Cash from Investing (TTM) Benchmarks
iBio Inc | 8.285M |
Flora Growth Corp | -0.234M |
Lixte Biotechnology Holdings Inc | -- |
Replimune Group Inc | 51.25M |
ABVC BioPharma Inc | -0.3602M |